Form D — Rivus Pharmaceuticals, Inc.
0001773293-25-000002 · filed 2025-01-16
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $56,979,133
- Total sold
- $56,979,133
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Rivus Pharmaceuticals, Inc.
- CIK
- 1773293
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 501 LOCUST AVENUE, SUITE 301
CHARLOTTESVILLE, VA 22902 - Phone
- 703-456-8000
Related persons
-
Allen Cunningham · Executive OfficerCharlottesville, VA
-
Jayson Dallas · Executive OfficerCharlottesville, VA
-
Shaharyar Khan · Executive OfficerCharlottesville, VA
-
Tom O'Neil · Executive OfficerCharlottesville, VA
-
Rick Winningham · DirectorCharlottesville, VA
-
Francesco De Rubertis · DirectorCharlottesville, VA
-
Ian Smith · DirectorCharlottesville, VA
-
Erin Lavelle · DirectorCharlottesville, VA
-
Robert Schott · Executive OfficerCharlottesville, VA
-
Derek DiRocco · DirectorCharlottesville, VA
View original on SEC EDGAR.